Articles from July 2025

Iowa Innovation Leadership Fellows Announced for 2025-2026
Monday, July 28, 2025
12 graduate trainees have been selected from a competitive pool of outstanding applicants to participate in the Iowa Innovation Leadership Fellows Program, a year-long educational experience designed to immerse them in the dynamic world of healthcare innovation.

Siddhanth’s Path from Mumbai to Monoclonal Antibodies
Friday, July 25, 2025
Siddhanth Hejmady’s journey into pharmaceutical sciences started back in Mumbai, where his passion for chemistry and biology led him to pursue pharmacy in undergrad. He describes it as the perfect intersection of both fields: how drugs are made, formulated, and ultimately used to help people.

Biomanufacturing In Real Life
Friday, July 25, 2025
If you’re unsure of your career path but interested in science, medicine, or making a difference, biomanufacturing might be the field you didn’t know you were looking for. Just ask Dr. James Byrne, Assistant Professor of Radiation Oncology and Biomedical Engineering at the University of Iowa, who combines patient care with lab research to bridge the gap between science and real-world impact.

Ashley Cooney’s Path from Student to Faculty
Monday, July 21, 2025
Ashley Cooney, Ph.D., didn’t just attend the University of Iowa — she built her entire academic and professional life here. From undergraduate student to postdoctoral scholar, and now a faculty member and 2024–2025 Iowa Innovation Leadership Fellow, Cooney’s journey proves that sometimes staying in one place can lead to remarkable growth.

Field Medical Closes Oversubscribed $35 Million Series B to Advance Development of FieldForce™ Pulsed Field Ablation Platform
Thursday, July 10, 2025
BioStar Capital and Cue Growth co-lead financing to accelerate pivotal trial readiness and expand the ventricular tachycardia (VT) treatment market

Boston Scientific receives FDA approval for expanded labeling of FARAPULSE™ Pulsed Field Ablation System
Thursday, July 10, 2025
The FARAPULSE PFA System now approved for pulmonary vein and posterior wall ablation in patients with persistent atrial fibrillation